summit study tirzepatide Another "Positive" Heart Failure Trial that Falls Short SUMMIT: Tirzepatide a 'Huge Win'
Description
A retrospective cohort study of 114 patients diagnosed with prolactinomas between 2007 and 2017 was conducted
Here's what the research actually say
Semaglutide is a powerful drug, but its misuse and self-medication are becoming a serious concern
pH and buffer strength effects were assessed at 25C and 40C
This review explores the immunomodulatory impact of gut-derived metabolites in IS, with a focus on short-chain fatty acids (SCFAs) and other bioactive substances
What it is
